Cargando…
Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency
BACKGROUND: The United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) have collaborated in good clinical practice (GCP) inspections since September 2009. The two agencies operate under different regulatory frameworks for GCP oversight. No systematic assessments of GCP...
Autores principales: | Sellers, Jenn W., Mihaescu, Camelia M., Ayalew, Kassa, Kronstein, Phillip D., Yu, Bei, Ning, Yang-Min, Rodriguez, Miguel, Williams, LaKisha, Khin, Ni A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356921/ https://www.ncbi.nlm.nih.gov/pubmed/35610469 http://dx.doi.org/10.1007/s43441-022-00417-w |
Ejemplares similares
-
Correction to: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency
por: Sellers, Jenn W., et al.
Publicado: (2022) -
Publisher Correction: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency
por: Sellers, Jenn W., et al.
Publicado: (2022) -
Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines Agency
por: Ayalew, Kassa, et al.
Publicado: (2022) -
Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections
por: Geyer, Andrea Renata Cornelio, et al.
Publicado: (2018) -
Actinomycosis and U. S. Meat Inspection
por: Williams, W. L.
Publicado: (1892)